Company Overview of Intercell USA, Inc.
Intercell USA, Inc. is a biopharmaceutical company that focuses on furthering the science and product application of transcutaneous immunization (TCI) in the prevention and treatment of infectious and autoimmune diseases, cancer, and allergies. The company focuses on the delivery of vaccines and immunostimulants to the skin through transcutaneous immunization technology. Intercell USA, Inc. was formerly known as Iomai Corporation and changed its name to Intercell USA, Inc. in August 2008 as a result of its acquisition by Intercell Ag. The company was founded in 1997 and is based in Gaithersburg, Maryland. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Valneva SE.
20 Firstfield Road
Gaithersburg, MD 20878
Founded in 1997
Key Executives for Intercell USA, Inc.
Intercell USA, Inc. Key Developments
Similar Private Companies By Industry
|TwoF, Inc.||United States|
|Bridger Technologies, Inc.||United States|
|EyeCyte, Inc.||United States|
|Rodin Therapeutics Inc.||United States|
|Impel Neuropharma Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Intercell USA, Inc., please visit www.iomai.com. Company data is provided by Capital IQ. Please use this form to report any data issues.